The news roundup for the week ending 17 June 2016.
Big deal: Cambridge wins big returns
Cambridge Enterprise comes out on top for money returned on investments with impressive numbers across the board.
Imperial exits Alkion Biopharma
Imperial Innovations exits its investment in Imperial College London spinout Alkion Biopharma, selling its shares to chemical company Evonik Industries.
Imperial Innovations furthers its commitment to Featurespace, a behavioural analytics spinout of Cambridge, by investing in the company for the third time.
StartX details Accuragen investment
Stanford University’s StartX returns to back Accuragen, a graduate of the accelerator, by taking part in its $40m funding round.
University of Montana Foundation backs Next Frontier Capital’s inaugural fund that supports technology and healthcare companies in the state.
Chile centralises tech transfer
Chile brings together 26 universities and 12 science laboratories with a fund to centralise technology transfer with three hubs in the country.
Monash and Melbourne research $59m fund
The two Australia universities come together to create a biomedical research enterprise called M2 Venture Catalyst with the backing of the state of Victoria.
Nomadd wanders towards series A
The Kaust Innovation Fund backs Nomadd, an automated cleaning system for solar panels, spun out of King Abdullah University of Science and Technology, in its $1m series A round.
Cambridge casts new spinout Phomera
Phomera Technologies unlocks an industrial process to replicate the colour-changing properties of butterfly wings.
Finance for Business North East invests $173,000 in Hexislab, a company using machine learning to identify compounds for skincare.
Rgenix generates $33m in series B round
Novo and Sofinnova Partners have co-led a series B round for Rgenix, a spinout of Rockefeller University that hopes to enter two immunotherapies into clinical trials this autumn.
